History of Neurodevelopmental Disorders Linked to Seminoma
WEDNESDAY, May 10, 2023 -- Having a history of neurodevelopmental disorders is associated with an increased risk for testicular germ cell tumors (TGCTs), according to a study published online April 24 in the British Journal of Cancer.
Anna K.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 10, 2023 Category: Pharmaceuticals Source Type: news
Treatment De-Escalation Shows Promise in Testicular Cancer
(MedPage Today) -- A reduced dose of chemotherapy and involved node radiotherapy (INRT) may be viable for patients with stage IIA or IIB seminoma of the testis, results from a phase II study suggested.
In a group of 116 patients, a single-dose... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - November 3, 2022 Category: Radiology Source Type: news
De-escalation Strategy in Seminoma: An Alternative Option? De-escalation Strategy in Seminoma: An Alternative Option?
A de-escalation strategy in stage IIA and IIB seminoma had a progression-free survival outcome similar to that of standard care and could potentially offer an alternative option.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 14, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Surveillance After Testicular Cancer: Reduced Radiation Exposure Surveillance After Testicular Cancer: Reduced Radiation Exposure
Two new approaches to surveillance imaging after treatment of stage I testicular seminoma sharply reduced or eliminate radiation exposure in the phase 3 TRISST study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 1, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
' Attractive' Option for Early Metastatic Seminoma'Attractive' Option for Early Metastatic Seminoma
For early-stage seminoma that metastasizes to one or two retroperitoneal lymph nodes, surgical excision is an"attractive" alternative, according to an investigator from the phase 2 SEMS trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 17, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Testicular Seminoma During Transgender Woman Hormone Therapy Testicular Seminoma During Transgender Woman Hormone Therapy
Gender-affirming hormone therapy unmasked an unsuspected hCG-secreting testicular seminoma in a transgender woman. How was this case diagnosed?Journal of the Endocrine Society (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 4, 2020 Category: Radiology Tags: Diabetes & Endocrinology Journal Article Source Type: news
Seminoma: Risk-Adapted Strategy Could Mean Less Toxic Chemo Seminoma: Risk-Adapted Strategy Could Mean Less Toxic Chemo
Early use of FDG-PET in chemotherapy can identify men with low-volume seminoma who have highly chemosensitive disease, enabling them to safely skip the standard chemotherapy regimen with its toxicity.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 24, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
' Less Is More' When it Comes to Testicular Cancer Chemo, Study Suggests
THURSDAY, Jan. 9, 2020 -- Treatment with half the typical amount of chemotherapy can still prevent the return of one type of testicular cancer, a new study suggests.
Giving patients with the " non-seminoma " form of testicular tumor just one cycle of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 9, 2020 Category: General Medicine Source Type: news
Paradigm Shift in Treatment of Testicular Seminoma? Paradigm Shift in Treatment of Testicular Seminoma?
Retroperitoneal lymph node dissection (RPLND) could become a first-line option in testicular seminoma, as it has lower toxicity than standard care.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 28, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
UCLA scientists use stem cells to study genetics of germ cell tumors
UCLA researchers have made new inroads into understanding germ cell tumors, a diverse and rare group of cancers that begin in germ cells — the cells that develop into sperm and eggs. The researchers developed a protocol to recreate germ cell tumor cells from stem cells and used the new model to study the genetics of the cancer.Their findings could point the way toward new drugs to treat germ cell tumors, which account for around 3 percent of all cases of childhood and adolescent cancer.The study, published in Stem Cell Research, was led by Amander Clark, a UCLA professor of molecular cell and developmental biology and a ...
Source: UCLA Newsroom: Health Sciences - January 29, 2018 Category: Universities & Medical Training Source Type: news
Airman Reflects on His Battle with Testicular Cancer
Tech. Sgt. Nathan Combs tells of his fight with stage II non-seminoma, a cancer that affects the testicle but is curable in almost 90% of cases (Source: Disabled World)
Source: Disabled World - November 21, 2016 Category: Disability Tags: Your Disability Stories Source Type: news
Radiotherapy more effective than chemotherapy for early stage II testicular cancer
A large study of testicular cancer patients has shown that radiation therapy is a better treatment than chemotherapy for patients with stage IIa disease (where one or more regional lymph nodes contain cancer cells but they are less than 2 cm in diameter). These findings are important because, until now, there has been little evidence about which treatment for testicular seminoma is more effective. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 2, 2016 Category: Science Source Type: news
Radiotherapy more effective than chemotherapy for early stage II testicular cancer
(European Society for Radiotherapy and Oncology (ESTRO)) A large study of testicular cancer patients has shown that radiation therapy is a better treatment than chemotherapy for patients with stage IIa disease (where one or more regional lymph nodes contain cancer cells but they are less than 2 cm in diameter). These findings, presented at the ESTRO 35 conference and published simultaneously in Clinical Oncology, are important because, until now, there has been little evidence about which treatment for testicular seminoma is more effective. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2016 Category: Global & Universal Source Type: news
Rwanda: Men With Testicular Cancer Can Have Children
[New Times] Testicular cancer is comprised of the seminoma cancer type and non-seminoma cancer type. These cancers grow from germ cells that make sperms in the body. (Source: AllAfrica News: Pregnancy and Childbirth)
Source: AllAfrica News: Pregnancy and Childbirth - February 8, 2016 Category: OBGYN Source Type: news
ASCO: Post-Surgery Surveillance Found Safe in Seminoma
Surveillance of patients with stage I seminoma following orchiectomy can spare a majority of patients from adjuvant chemotherapy with a low risk of relapse, according to results presented at the 2013 ASCO meeting. (Source: Cancer Network)
Source: Cancer Network - June 17, 2013 Category: Cancer & Oncology Source Type: news
